MSN Laboratories Gets CDSCO Panel Nod To study Brexpiprazole Tablets Dr. Divya Colin2 May 2025 6:00 PM ISTNew Delhi: Considering the bioequivalence study of Brexpiprazole Tablets 0.25mg /0.5 mg/1mg/2mg/3mg/4mg, the Subject Expert Committee (SEC) functional...
'Ghatiya' Is Hyperbole, Not Defamation: HC Declines to Restrain Influencers' Criticism of Protein Supplement Farhat Nasim1 May 2025 7:41 PM ISTNew Delhi: In a significant ruling defining the boundaries of free speech and online criticism in the digital age, the Delhi High Court has refused to...
Revise study protocol: CDSCO Panels tells Lupin on Ranibizumab Solution for Injection 10 mg/mL Dr. Divya Colin30 April 2025 6:00 PM ISTNew Delhi: Responding to the drug major Lupin's proposal to conduct phase IV clinical trial of the ophthalmic drug Ranibizumab Solution for Injection...
61 Formulations declared Not of standard quality as per data provided by states: CDSCO Drug Alert Dr. Divya Colin29 April 2025 6:00 PM ISTNew Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central Drug Standard Control...
Minor Drug Law Violations Can Now Be Settled Without Trial: Health Ministry Issues Rules Farhat Nasim28 April 2025 7:21 PM ISTNew Delhi: The Ministry of Health and Family Welfare has notified the Drugs and Cosmetics (Compounding of Offences) Rules, 2025, allowing...
CDSCO panel rejects Akums Drugs Proposal for PK/PD study of Cholecalciferol aqueous injection Dr. Divya Colin27 April 2025 6:00 PM ISTNew Delhi: Noting that adequate safety measures are not incorporated in the proposed protocol, the Subject Expert Committee (SEC) functional under the...
Cough Syrup Warning Will Not Affect Existing Stock: HC Relief to Glenmark, Zuventus Farhat Nasim26 April 2025 7:09 PM ISTNew Delhi: In a major relief to pharma companies Glenmark Pharmaceuticals Ltd. and Zuventus Healthcare Ltd., the Delhi High Court has ruled that the...
Batch of Telma AM earlier classified as NSQ now flagged as Spurious Farhat Nasim25 April 2025 8:30 PM ISTNew Delhi: Through a recent revised Drug Alert for January 2025, the Central Drugs Standard Control Organisation (CDSCO) has classified a batch of...
Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight Farhat Nasim24 April 2025 6:29 PM ISTMumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...
Drug Alert: 70 Drug Samples Fail To Clear CDSCO Test, 1 Declared spurious Dr. Divya Colin23 April 2025 6:00 PM ISTNew Delhi: With an aim to make stakeholders aware of the not-of-standard-quality (NSQ) batches identified in the market, in its latest drug alert, the...
As Ozempic, Wegovy Take Priority, Novo Nordisk Winds Down Insulin Portfolio In India Farhat Nasim22 April 2025 7:04 PM ISTNew Delhi: Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand. This...
One FDC Declared Rational, 6 Require Phase IV Data: CDSCO Issues Fresh Guidelines Susmita Roy21 April 2025 6:00 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health and Family Welfare, has issued a detailed directive...
